A detailed history of Sns Financial Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Sns Financial Group, LLC holds 4,684 shares of BSX stock, worth $422,543. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,684
Previous 4,677 0.15%
Holding current value
$422,543
Previous $360,000 8.89%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$72.96 - $84.0 $510 - $588
7 Added 0.15%
4,684 $392,000
Q2 2024

Jul 25, 2024

BUY
$67.33 - $77.71 $807 - $932
12 Added 0.26%
4,677 $360,000
Q1 2024

Apr 24, 2024

BUY
$57.6 - $68.62 $633 - $754
11 Added 0.24%
4,665 $319,000
Q4 2023

Jan 22, 2024

SELL
$48.64 - $57.81 $2,042 - $2,428
-42 Reduced 0.89%
4,654 $269,000
Q3 2023

Oct 19, 2023

BUY
$50.19 - $54.68 $552 - $601
11 Added 0.23%
4,696 $247,000
Q2 2023

Jul 17, 2023

SELL
$49.72 - $54.64 $447 - $491
-9 Reduced 0.19%
4,685 $253,000
Q1 2023

Apr 28, 2023

BUY
$45.09 - $50.03 $1,668 - $1,851
37 Added 0.79%
4,694 $234,000
Q4 2022

Jan 25, 2023

BUY
$39.56 - $47.22 $184,230 - $219,903
4,657 New
4,657 $0
Q2 2022

Jul 22, 2022

SELL
$35.24 - $47.1 $161,504 - $215,859
-4,583 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$40.9 - $45.1 $187,444 - $206,693
4,583 New
4,583 $203,000
Q1 2020

May 07, 2020

SELL
$25.83 - $45.71 $120,186 - $212,688
-4,653 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$37.87 - $45.37 $176,209 - $211,106
4,653 New
4,653 $211,000
Q4 2018

Feb 05, 2019

SELL
$31.73 - $39.04 $219,761 - $270,391
-6,926 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $185,893 - $237,700
6,926 New
6,926 $226,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Sns Financial Group, LLC Portfolio

Follow Sns Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sns Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sns Financial Group, LLC with notifications on news.